Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
Heart Failure With Preserved Ejection Fraction in the Young
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure